Prokidney reports full year 2024 financial results and business highlights

Winston-salem, n.c., march 17, 2025 (globe newswire) -- prokidney corp. (nasdaq: prok) (“prokidney”), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (ckd), today announced financial results and business highlights for the year ended december 31, 2024.
prok Ratings Summary
prok Quant Ranking